& of course, for those who have the time, I highly recommend reading the full paper, here: doi.org/10.1016/j.ajcn…
But for those who prefer video or TW thread... HERE WE GO...
3/18) What the researchers did in this paper is perform a secondary analysis of pre-existing data from a 12-month RCT: the DIETFITS trial in which 609 adults aged 18-50 without diabetes were randomized to either a 12 m Low-carb diet (LCD) or low-fa diet (LFD).
4/18) Initial data showed LCD led to more weight loss than LFD at 3 and 6 mo, but that the between group diff in weight loss lost significance at 12 months
This was taken to be evidence against the CIM. However, as this paper reveals, there is more nuance to the story...
5/18) One important ? is why significance was lost at 12mo?
2 reasons...
i) Participant dropout. Each group lost ~80 participants, diminishing statistic power
AND
ii) Diet convergence: ‘Carb creep’ in the LCD group (132g/d) + carb drop in the LFD group (213g/d)
6/18) Even setting aside the dietary convergence, when missing data was imputed, the LCD group did in fact lose more weight at 12 m than the LFD group at all time points.
7/18) Moving on, Fig 2 shows a model of predictors of weight loss ➡️ larger circumferences represent better predictors of weight loss
🍽️🍽️Total fat & Calories were poorer predictors of weight loss
🍩🥭Carbs & GI and sugar are the superior predictors
Consistent with the CIM
8/18) In Table are 2 models examining the mediators of weight loss
When you add in Glycemic Load (GL) is added to the model in model 2, GL is highly significant (p=5.7x10-5) and calories (p=0.80) LOSE significance!
Let’s expand on this point...
9/18) Many think that LCD works bc it just makes you eat fewer calories, but that it’s actually the drop in calorie intake that’s driving the weight loss. This certainly is a contributing factor but...
10/18) These results show that GL is better than caloric intake at predicting weight loss, which may appear counterintuitive BUT can be made intuitive if you think about the components of Energy balance: Calories in & Calories out...
11/18) The CICO model, when taken in CLINICAL practice, usually focuses on CI because accurately measuring CO accurately is next to impossible (think, NEAT, TEF, body temp, etc.)
12/18) By contrast, if GL influences the hormonal milieu of the body, it dictates NOT ONLY hunger and caloric intake (CI) but also homeostatic mechanisms to maintain energy equilibrium, or tip it one way or another, through CO: NEAT, body temp, etc.
13/18) Simply put, one could actually make the argument that the CIM is actually a superior real-life ‘CICO’ model than the standard cal counting CICO model itself!
LOL If that doesn’t make sense, read ^ again and watch video for completeness
14/18) Other cool data presented in this paper consistent with the results already shared is that, in fig 5, a biomarker of low-carb/GL (TG/HDL) was strongly associated with weight loss whereas a biomarker of fat reduction (LDL+HDL) was not.
15/18) Finally, and beautifully, the authors put a bold prediction of the CIM to the test which is that those with higher basal insulin secretion would benefit most for GL reduction. Again, this is b/c in the CIM GL influences insulin to cause fat storage.
16/18) So, if someone naturally is an insulin hyper-secreter, the effect of the model is simply going to be amplified. As a result, those who secrete a lot of insulin probably benefit the most from reducing GL. Is that the case? As it turns out yes!
17/18) Clearly see an interaction b/w GL reduction and basal insulin
As you can see in the back left row, these persons who reduced GL most and were the insulin hyper secreters, lost the most weight!
18/18) In summary, this paper provides powerful evidence for two prediction of the CIM: (1) GL > Calories as a predictor of weight loss and (2) insulin hyper secreters benefit most from carb reduction.
🧠Saffron for Depression: The Science, the Studies, and the Recipes🧠
1/5) What if I told you that the kitchen spice – Saffron – could treat depression?
It may sound too good to be true, but that claim is supported by a growing pile of human randomized controlled trials (RCTs) and sensible biological mechanisms.
I’m going to share two of these studies, explain the neuroscience, and direct you to more learning.
This golden spice really might be the next big thing in mental health!
References are in the newsletter linked at the end. #saffron #depression #mentalhealth
2/5) Saffron vs SSRI (RCT)
This double-blind randomized controlled trial compared 6 weeks of saffron supplementation (30mg/d) vs Prozac (fluoxetine), a commonly prescribed selective serotonin reuptake inhibitor (SSRI).
Impressively, the saffron performed equal to the fluoxetine!
You can see the results over 6 weeks here, with the Hamilton Rating Scale for Depression dropping in lock step between the treatments.
The absolute decrease in both treatments was >12. What does that number mean?
Well, in clinical trials, there’s a key distinction between a “statistically significant” difference and a “clinically significant” difference. A “statistically significant” difference means there was a detectable numeric difference, as in over time or between groups. Conversely, a “clinically significant” difference means that size of the change was detectable and meaningful for the patient.
Now while it’s somewhat arbitrary, a clinically meaningful change in this depression scale is ~5 points, which means a ~12-point drop is impressive and is clinically substantial!
Note on Side Effects: One presumed advantage of saffron is that it could have fewer side effects than prescription medications. In this first small pilot trial, there is an apparent trend to lower side effects in the saffron group vs SSRI. To see that table, click on the link at the end of this thread.
3/5) Saffron for Mental Health - Meta-Analysis
Rather than working through another 20+ studies, I want to share with you excerpts from a meta-analysis of 23 RCTs conducted on saffron for mental health, including depression and anxiety:
👉 [M] eta-analysis found a significant and large positive effect size for saffron reducing symptoms of depression in comparison with placebo.
👉When compared with antidepressants medications, there was no significant difference between saffron and medications.
👉Meta-analysis of studies that investigated the effect of saffron as an adjunct to pharmacotherapy reported a large significant benefit from saffron supplementation.
In simpler terms:
👉Saffron’s effect alone with large and positive for mental health
👉Saffron performed as well as commonly prescribed medications
👉Saffron provided additional benefit when stacked on prescription medications
1/5) In this study, 64 adults endured 2 hours of cold exposure near their shivering threshold.
🤔Results🤔
Massive changes in signaling lipids, including omega-6 and omega-3 fats and their derivatives, endocannabinoids and specific pro-resolving mediators.
On net, the changes reflected a signature of improved cardiometabolic health 🫀❤️🔥 #coldplunge #hearthealth
2/5) 🥶Some specific Omega-6 and 3 Changes🥶
👉39% Increase in the omega-6 oxylipin 12,13-dihydroxy-9Z-octadecenoic acid (12,13-DiHOME). This oxylipin has been shown to increase the uptake of
fatty acids by brown fat and skeletal muscle.
🔥But even more impressive than the omega-6 response was the omega-3 response...
👉17 out of 17 omega-3 fats and their derivatives increased in the blood after cold exposure, by an average of 77%
👉The most prominent change, with an increase of 155%, was in 14- hydroxy-docosahexaenoic acid (14-HDoHE), which has been shown to inhibit activation of platelets involved in blood clots, increase blood flow, and inhibit inflammation.
👉And increases were noted in Resolvin D5, a powerful anti-inflammatory compound that inhibits the production of inflammatory molecules, like IL-6, reduces pain and protects various organs from inflammatory challenges.
3/5) And there were changes in endocannabinoids!🪴
There was an increase in anandamide, which binds the CB1 receptor – a key receptor involved in the effects of THC.
So, I’ll let you put 2+2 together on that... I’m not saying that a cold plunge will make you ‘high’ per se, but it’s an interesting mechanistic overlap… and one that overlaps with people’s experiences.
☕️Coffee for Gut Health?! 🦠 New Research will have you Express-O-ing excitement!
This thread will reveal what new research in Nature Microbiology has discovered, tell you how much coffee to drink to get the health benefits, compare caffeinated vs. decaf, and more. I hope you’ve had a cup or two because you’ll need focus for this. (🔗link at the end)
1/8) Quick Background on the Health Benefits of Coffee
First, coffee intake has already been associated with lower mortality, reduced cardiovascular disease-related death, and a lower risk of type 2 diabetes. But nutritional epidemiology—the study of diet and health outcomes in large populations—has its limitations because it can only look for correlations.
To solidify coffee’s health halo, what we want is a complementary biological mechanism, a physiological story that helps it all make sense. #coffee #microbiome
2/8) Coffee Changes the Microbiome: Lawsonibacter asaccharolyticus
So, let’s introduce the protagonist of this story, a gut bacterium named Lawsonibacter asaccharolyticus. (I know, it sounds kind of like a Harry Potter spell.)
To discover the Lawsonibacter asaccharolyticus–coffee link, the researchers took information on food intake, including > 150 specific foods with associated and microbiome samples, then look for connections between specific foods and microbiome signatures.
☕️Among the >150 foods analyzed; coffee stood out for having the clearest microbiome signature.
3/8) For further analyses, they broke participants into three groups:
👉“Never” drinkers: Consumed less than three cups per month
👉“Moderate” drinkers: Consumed more than this but fewer than three cups per day
👉“High” drinkers: Consumed more than three cups per day
The strongest correlation between coffee consumption and the microbiome was Lawsonibacter asaccharolyticus. And—because I know you’re wondering, as I was when reading the paper—this association was independent of caffeine.
Why do we sleep? 😴And what caused “Brain Constipation? 🧠💩 New research in @CellCellPress
(Link at end, w/ exclusive clip from first author 🤓)
1/4) A Key Function of Sleep is to clear metabolic wastes from the brain.
This function is carried out by the “glymphatic system,” a series of channels that expand as blood vessels constrict. Deep non-rapid eye movement (NREM) sleep is prime time for glymphatic systema and brain waste removal. But a key question that has remained unanswered until now is *HOW* is this system regulated?
🧠Norepinephrine Regulates Glymphatic Flow🌊
The researchers find a group of neurons in the brain stem bathes the brain in norepinephrine pulses while we sleep. Norepinephrine is a vasoconstrictor, and these pulses therefore generate waves of blood vessel constriction that enhance glymphatic flow and metabolic waste removal from the brain.
🧠 Brain Constipation?💩
By way of analogy, think about your gastrointestinal system: Your intestines use rhythmic contractions to move waste out. If that process stops—you get constipated. Now imagine your brain has a similar waste-removal system... but instead of food, it’s clearing out toxic metabolic byproducts. If something blocks that process, you get brain constipation.
What causes brain constipation?
* if I do say so, I think this is a video @hubermanlab, cc @IanGMackey @R_Mohr, and @bryan_johnson and @NTFabiano will each enjoy -- ... and if you want more on glymphatics and sleep, let me know
* Don't miss an exclusive clip from the first author of the research in the full video, link at the end.
2/4) The researchers then asked the provocative question: What do certain sleep medications, specifically Zolpidem, do to norepinephrine pulses and glymphatic function?
💩 In brief, they find that the sleep medication impairs the normal oscillations in norepinephrine and decreases glymphatic flow. The implication is that long-term use could contribute to a build-up of metabolic debris in the brain and, possibly, long-term negative consequences like cognitive decline.
Indeed, long-term human studies have linked Zolpidem to higher rates of dementia and Alzheimer’s disease.
Fortunately, this does not appear to be the case for other medications that are often used to help with sleep, like the atypical anti-depressant trazodone. In fact, there are suggestions that this medication might improve sleep architecture and is associated with lower rates of dementia.
3/4) The Good News: With advancements in technology, maybe we will soon be able to enhance glymphatics efficiency and ‘brain cleaning,’ including during sleep and perhaps even during waking hours. In my biomedical fantasy, I could rinse my brain between blocks of work while watching a Marvel Movie, or Harry Potter, Game of Thrones. What a dream!
1/8) Yesterday @bryan_johnson claimed he's "aging slower than anyone in the world." This is incorrect by his own measurement tool.
But this thread isn't just a fact-check. It's an assessment of the "Pace of Aging Clock," and how I think one should interpret these data.
🔗 to letter and more data at the end🔗
cc @Derek_Fitness @JEverettLearned
2/8) First, what is the DunedInPACE Score?
PACE stands for Pace of Aging Calculated from the Epigenome—and the score is meant to measure the rate of biological change, with a value of 1.0 = 1 year of biological change per calendar year.
As opposed to the other aging clocks, which were developed by comparing people of different ages, DunedinPACE was developed by following a cohort of individuals who were all the same chronological age and measuring changes in biomarkers reflecting the health and integrity of different organ systems (cardiovascular, renal, hepatic, immune, etc.), then normalizing to 1, such that 1.0 indicates 1 year of biological change per 12-month calendar year.
3/8) Bryan Johnson previously boasted a value of to 0.66 as his DunedinPACE rate of aging score, suggesting that he’s biologically aging at ~66% or ab out 2/3rd of the average person. Then, around this past New Year's, he reported a DunedinPACE score of 0.57, a ‘personal best’ according to Bryan, claiming that his birthday is every 21 months (12 / 0.57). Yesterday, he claimed a score of 0.48.
Nuance Note: It’s not clear to me if this is a result of:
1. an actual downward trend in his score reflecting true slowed pace of aging
2. a function of test variability and the fact he just has more measures from which to choose and report
3. if he’s modifying his protocols to ‘optimize’ his metric, but without translation to bona fide slowing of biological age. More on this in a moment…
Ketogenic Diet for Parkinson's Disease - Mega Post
(🔗 to Deep Dive Video at the End.)
Let’s cut to the chase: my answer is a cautious but confident “Yes.”
However, it’s not that simple. In this thread, I’ll break down the “what,” “how,” and “why” of a Ketogenic Diet for Parkinson’s Disease.
1/9) First, what is Parkinson’s disease? 🧠
Parkinson’s disease is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms. The motor symptoms are what most classically stand out and include cardinal features of:
👉1) Tremor
👉2) Bradykinesia, which means slowness in movement
👉3) Rigidity, that can make it hard to walk, write, speak, or express facial expressions
👉4) Postural instability, which can lead to falls.
In terms of non-motor symptoms, patients often experience issues with smell, gastrointestinal upset, and sometimes mood disturbances like depression.
How common is Parkinson’s disease?
👉Second most common neurodegenerative disease, behind Alzheimer’s.
👉Impacts >10 million people worldwide and is growing in prevalence much faster than Alzheimer’s disease. If it were an infectious disease, Parkinson’s would be labeled a pandemic.
cc @Metabolic_Mind @bschermd @janellison @ChrisPalmerMD
2/9) What causes Parkinson’s disease? 🧠🤔
Parkinson’s disease is caused by the death of dopamine producing neurons in the brain’s “substantia nigra.” This translates to ‘black substance’ and is a little patch of brain in the midbrain motor system in the brain.
Specifically, Parkinson’s disease is characterized by the aggregation of misfolded “alpha synuclein” protein – the hallmark of Parkinson’s disease – leading to the death of these dopamine producing substantia nigra neurons.
As more neurons die… the disease gets worse. And current standard of care is, basically, replacing the missing dopamine with dopamine supplementation of some form. However, as more neurons die, the underlaying disease progresses, the medications become less effective, and the disease typically gets worse until…
👉👉Well, that’s why we really need better treatments.
3/9) But here’s something interesting about these dopamine neurons in the midbrain that die off in Parkinson’s disease: They are huge with many branches (this is called arborization), are relatively few, and are very energy hungry. ⚡️⚡️⚡️
They also have a calcium-pacemaking activity that gobbles up energy like a hungry teenager.
All this means, these substantia nigra neurons are particularly metabolically active cells and are, therefore, especially susceptible to energy deprivation. And when the neurons are starved of energy, they die.
But what if we could rescue energy metabolism in substantia nigra neurons? Could we slow or stop Parkinson’s disease?